(Q70698048)
Statements
Phase I clinical trial of recombinant human interleukin-3 combined with carboplatin in the treatment of patients with recurrent ovarian carcinoma (English)
J J Rusthoven
E Eisenhauer
J Mazurka
H Hirte
G O'Connell
A Muldal
H X Lu
N Onetto
K Swenerton